Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of favorable developments. This biotech firm focused on advancing...

DAWN : 13.42 (-2.61%)
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it is supporting...

KZIA : 0.2351 (+2.84%)
DAWN : 13.42 (-2.61%)
NVS : 107.48 (+0.96%)
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 63.23 (+0.65%)
INTC : 30.83 (-0.45%)
AMD : 155.54 (-4.11%)
COIN : 228.62 (+2.88%)
ITX.E.DX : 46.250 (-0.28%)
YEXT : 5.28 (-1.31%)
GDYN : 10.60 (+0.86%)
VXRT : 0.6600 (-1.09%)
DAWN : 13.42 (-2.61%)
Why Shares of Day One Pharmaceuticals Are Up Monday

The clinical-stage biotech released early trial news regarding its lead therapy candidate.

DAWN : 13.42 (-2.61%)
Stock Index Futures Mixed on Pressure from Rising Bond Yields, Oil Prices Rise After Saudi Output Cuts

June S&P 500 futures (ESM23) are up +0.01%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.25% this morning as market participants digested the U.S. debt ceiling agreement, while U.S. Treasury...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
LULU : 297.96 (-0.25%)
MMM : 102.94 (+0.73%)
AMZN : 194.42 (+0.61%)
VOLCB.S.DX : 33.248 (+1.41%)
MRO : 28.91 (+0.84%)
DVN : 47.84 (+0.93%)
OXY : 63.41 (+0.60%)
DBRG : 13.44 (-1.90%)
RAIN : 1.2100 (-1.63%)
EVAX : 2.89 (-0.34%)
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029

EQNX::TICKER_START (NASDAQ:KTTA),(NASDAQ:SWTX),(NASDAQ:DAWN),(NASDAQ:VSTM),(NASDAQ:KNTE) EQNX::TICKER_END

KTTA : 5.25 (+3.74%)
DAWN : 13.42 (-2.61%)
SWTX : 37.77 (+0.27%)
VSTM : 3.14 (+5.37%)
KNTE : 2.65 (-0.38%)
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029

/PRNewswire/ -- Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue....

KTTA : 5.25 (+3.74%)
SWTX : 37.77 (+0.27%)
DAWN : 13.42 (-2.61%)
VSTM : 3.14 (+5.37%)
KNTE : 2.65 (-0.38%)
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations

/PRNewswire/ -- USA News Group - The world's biggest cancer conference is set to roll again at American Society of Clinical Oncology (ASCO) 2023, with...

ONC.TO : 1.35 (-2.17%)
GILD : 69.87 (+1.84%)
IMGN : 31.23 (unch)
DAWN : 13.42 (-2.61%)
LEGN : 45.68 (+3.14%)
ONCY : 0.9999 (+1.00%)
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END

ONCY : 0.9999 (+1.00%)
ONC.TO : 1.35 (-2.17%)
GILD : 69.87 (+1.84%)
IMGN : 31.23 (unch)
DAWN : 13.42 (-2.61%)
LEGN : 45.68 (+3.14%)
Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting

VANCOUVER - USA News Group - The world’s biggest cancer conference is set to roll again at American Society of Clinical Oncology (ASCO) 2023, with in-person attendance back in full swing and already...

ONCY : 0.9999 (+1.00%)
ONC.TO : 1.35 (-2.17%)
GILD : 69.87 (+1.84%)
IMGN : 31.23 (unch)
DAWN : 13.42 (-2.61%)
LEGN : 45.68 (+3.14%)

Barchart Exclusives

Stock Market Forecast H2 2024: Will the 'AI Rally' Get a Reality Check?
Defying all pessimism, the S&P 500 Index rose almost 15% in the first half of 2024 on the back of strength in AI stocks. Here's the stock market forecast for the back half of 2024, and the key events that investors should watch. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar